title: Renal and systemic effects of atrial natriuretic factor.
abstract: A survey of the literature reporting the in vivo biological activity of atrial natriuretic factor (ANF) is presented. Both the atrial extracts, in which ANF was first identified, and the peptides which have more recently been synthesized, have been shown to possess diuretic and saluretic properties. In addition, ANF decreased blood pressure and affected levels of aldosterone, renin, vasopressin and guanosine 3',5'-cyclic monophosphate (cGMP). The available evidence concerning likely mechanisms of action of ANF are presented and a pivotal role of ANF is suggested for blood pressure and volume regulation.
authors.forename: A A
authors.initials: AA
authors.lastname: Seymour
mesh_terms: D000450:Aldosterone / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D009320:Atrial Natriuretic Factor; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D001834:Body Water / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005919:Glomerular Filtration Rate / Q000187:drug effects; D007668:Kidney / Q000098:blood supply / Q000187:drug effects*; D009124:Muscle Proteins / Q000494:pharmacology*; D051381:Rats; D012039:Regional Blood Flow; D012083:Renin / Q000097:blood; D014667:Vasopressins / Q000097:blood
chemical_list: D009124:Muscle Proteins; D014667:Vasopressins; D000450:Aldosterone; D009320:Atrial Natriuretic Factor; D012083:Renin; D006152:Cyclic GMP